An Outbreak of Streptococcus Endophthalmitis After Intravitreal Injection of Bevacizumab
- 1 February 2012
- journal article
- research article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 153 (2), 204-208.e1
- https://doi.org/10.1016/j.ajo.2011.11.035
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health Center (P30-EY014801)
- University of Miami from Research to Prevent Blindness
This publication has 13 references indexed in Scilit:
- Counterfeit Bevacizumab and EndophthalmitisNew England Journal of Medicine, 2011
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2011
- Pharmacotherapy for Neovascular Age-Related Macular Degeneration: An Analysis of the 100% 2008 Medicare Fee-For-Service Part B Claims FileAmerican Journal of Ophthalmology, 2011
- Endophthalmitis After Intravitreal Injection: Prevention and ManagementRetina, 2011
- ENDOPHTHALMITIS AFTER INTRAVITREAL ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR ANTAGONISTSRetina, 2011
- META-ANALYSIS OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION OF ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTSRetina, 2011
- Microbial contamination of syringes during preparation: The direct influence of environmental cleanliness and risk manipulations on end-product qualityAmerican Journal of Health-System Pharmacy, 2009
- Serratia marcescens endophthalmitis associated with intravitreal injections of bevacizumabEye, 2009
- SHORT-TERM SAFETY AND EFFICACY OF INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONRetina, 2006
- Endophthalmitis caused by streptococcus pneumoniaeAmerican Journal of Ophthalmology, 2004